PMID: 18319270
Question: Does confined placental mosaicism account for adverse perinatal outcomes in IVF pregnancies?
Correct Answer: no

======================= Launch the MCC process =======================
PMID: 18319270
Question: Does confined placental mosaicism account for adverse perinatal outcomes in IVF pregnancies?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**

The core question is whether confined placental mosaicism (CPM) is responsible for the adverse perinatal outcomes observed in pregnancies achieved through in vitro fertilization (IVF). Specifically, the inquiry seeks to determine if CPM is more prevalent in IVF/ICSI pregnancies compared to spontaneous conceptions and if this prevalence correlates with poorer perinatal outcomes in IVF pregnancies.

Key information to extract from the abstract includes:
- Incidence rates of CPM in IVF/ICSI versus spontaneous conception groups.
- Statistical significance of the differences observed.
- Incidence of fetal chromosomal anomalies in both groups.
- The study's conclusion regarding the role of CPM in adverse outcomes.

**2. Evidence Evaluation**

The study analyzed a substantial sample size of 20,885 pregnancies, with 235 in the IVF/ICSI group and 20,650 in the control group. The incidence of CPM was 1.3% in the IVF/ICSI group compared to 2.2% in the control group, yielding an odds ratio (OR) of 0.59 with a 95% confidence interval (CI) of 0.19-1.85. Additionally, fetal chromosomal anomalies were slightly higher in the IVF/ICSI group (4.3%) than in the control group (2.4%), with an OR of 1.81 (95% CI 0.95-3.42). Importantly, neither difference reached statistical significance.

The strength of the evidence lies in the large sample size and the retrospective multi-center approach, enhancing the reliability and generalizability of the findings. However, the wide confidence intervals and lack of statistical significance indicate a degree of uncertainty. Furthermore, missing data in the control group (143 cases) could influence the results, although the study accounted for this in their analysis.

The evidence is directly relevant to the question, addressing the incidence of CPM in both IVF/ICSI and spontaneous conception groups and its potential link to adverse perinatal outcomes.

**3. Conclusion**

Based on the provided abstract, CPM does not appear to be more prevalent in IVF/ICSI pregnancies compared to spontaneous conceptions, and it likely does not account for the adverse perinatal outcomes observed in IVF pregnancies. However, the lack of statistical significance and the presence of wide confidence intervals suggest that the evidence is not definitive. Therefore, while the study leans towards CPM not accounting for adverse outcomes in IVF pregnancies, the evidence is not entirely conclusive.

**4. Final Answer**

**My final choice is: "maybe"**
GPT selected: maybe

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether confined placental mosaicism (CPM) explains adverse perinatal outcomes in IVF pregnancies. Key information to assess:  
- The study compared CPM incidence between IVF/ICSI and spontaneous conceptions.  
- The abstract states the incidence of CPM was **lower** in IVF/ICSI (1.3%) than in controls (2.2%), with a nonsignificant odds ratio (0.59; 95% CI 0.19–1.85).  
- The study concluded that CPM does not account for adverse outcomes in IVF/ICSI.  

**2. Evidence Evaluation**  
- **Results**: The IVF/ICSI group had a **lower** CPM rate than the control group, contrary to the hypothesis.  
- **Statistical Significance**: The confidence interval for the odds ratio includes 1, indicating no statistically significant difference.  
- **Relevance**: The study directly addresses the question by comparing CPM incidence between groups and explicitly states that CPM is unlikely to explain adverse outcomes.  

**3. Conclusion**  
The evidence shows no increased incidence of CPM in IVF/ICSI pregnancies compared to spontaneous conceptions. Since CPM is less common in IVF, it cannot explain the poorer perinatal outcomes observed in IVF. The study’s conclusion aligns with this reasoning.  

**4. Final Answer:**  
**My final choice is: "no"**
Qwen selected: no

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether confined placental mosaicism (CPM) explains adverse perinatal outcomes in IVF pregnancies. The study compares CPM incidence in IVF/ICSI pregnancies versus spontaneous conceptions to determine if CPM is a contributing factor. Key information includes CPM rates, statistical significance of differences, and the study's conclusion.

**2. Evidence Evaluation**  
- **Results**: The incidence of CPM was lower in IVF/ICSI (1.3%) vs. controls (2.2%), but the difference was not statistically significant (OR 0.59, 95% CI 0.19–1.85). Fetal chromosomal anomalies were higher in IVF/ICSI (4.3% vs. 2.4%), but this was also not statistically significant.  
- **Strength/Reliability**: The study is retrospective, multi-center, and includes a large control group. However, the small IVF/ICSI sample size (n=235) and wide confidence intervals reduce statistical power.  
- **Relevance**: Directly addresses the hypothesis by comparing CPM rates between IVF and non-IVF pregnancies. The conclusion explicitly states CPM does not account for adverse outcomes in IVF.

**3. Conclusion**  
The study found no significant increase in CPM in IVF pregnancies and concluded that CPM is unlikely to explain adverse perinatal outcomes. Despite limitations (e.g., sample size), the evidence supports rejecting CPM as a primary cause.  

**4. Final Answer**  
**My final choice is: no**
DeepSeek selected: no

-------- Debate round 1 --------

----------------------- GPT's response -----------------------
GPT is generating the response...


**1. Position Statement**

**I agree with the shared perspective of Qwen and DeepSeek.**

**2. Evaluation of Other Models**

Both Qwen and DeepSeek have provided thorough analyses that align closely with the evidence presented in the medical literature abstract. They correctly identified that the incidence of confined placental mosaicism (CPM) is not increased in IVF/ICSI pregnancies compared to spontaneous conceptions. Furthermore, they noted that the odds ratios for CPM and fetal chromosomal anomalies were not statistically significant, reinforcing the conclusion that CPM likely does not account for adverse perinatal outcomes in IVF pregnancies. Their arguments are well-supported by the data and effectively address the key aspects of the question.

**3. Medical Analysis and Argumentation**

Upon reevaluating the evidence, it is clear that the incidence of CPM is not elevated in IVF/ICSI pregnancies. In fact, the observed CPM rate in the IVF/ICSI group (1.3%) is slightly lower than that in the control group (2.2%), although this difference is not statistically significant (OR 0.59; 95% CI 0.19–1.85). Additionally, while fetal chromosomal anomalies were somewhat higher in the IVF/ICSI group (4.3%) compared to controls (2.4%), this difference also did not reach statistical significance (OR 1.81; 95% CI 0.95–3.42).

The large sample size of the study enhances the reliability of these findings, and the multi-center retrospective design adds to the generalizability of the results. While the wide confidence intervals indicate some uncertainty, the lack of a significant increase in CPM among IVF pregnancies suggests that CPM is not a major contributing factor to adverse perinatal outcomes in this population. Therefore, the preponderance of evidence supports the conclusion that CPM does not account for the adverse outcomes observed in IVF pregnancies.

**4. Self-Questioning**

- **Has the rationale for my original choice truly been completely refuted?**
  
  Yes, the substantial evidence presented by both Qwen and DeepSeek, combined with a closer examination of the data, clarifies that CPM is not increased in IVF pregnancies. This directly challenges the uncertainty that led to the initial "maybe" choice.

- **Is the new choice better than my original choice?**
  
  Yes, the new choice ("no") is more aligned with the robust evidence provided and the consensus of the other models, providing a more definitive answer based on the available data.

- **Explain why you persist with or change your choice**
  
  Given that both Qwen and DeepSeek have provided compelling arguments supported by the study's findings, and upon reanalysis, it is evident that CPM does not play a significant role in adverse perinatal outcomes in IVF pregnancies. Therefore, it is appropriate to change the choice from "maybe" to "no."

**5. Final Decision**

**My final choice is: "no"**
GPT selected: no

----------------------- Qwen's response -----------------------
Qwen is generating the response...


**1. Position Statement**  
**I agree with the common viewpoint of GPT and DeepSeek** because their analyses align with the evidence provided in the abstract and my own evaluation. The study’s findings and conclusions are consistent across all models, and no critical gaps or misinterpretations were identified in their reasoning.  

**2. Evaluation of Other Models**  
- **GPT’s analysis** appropriately emphasizes the non-statistically significant odds ratios and the study’s robust design (large sample size, multi-center retrospective approach). However, it does not explicitly address potential limitations such as the small IVF sample size (n=235) or the wide confidence intervals, which could affect statistical power.  
- **DeepSeek’s analysis** correctly highlights the small IVF sample size and the resulting limitations in statistical power, which is an important caveat. However, it does not explicitly explain how the study’s conclusion about CPM’s lack of association with adverse outcomes logically follows from the data (e.g., lower CPM incidence in IVF).  

**3. Medical Analysis and Argumentation**  
- **Key Evidence from the Abstract**:  
  - The **incidence of CPM is lower** in IVF/ICSI pregnancies (1.3%) than in spontaneous conceptions (2.2%), despite IVF pregnancies having higher rates of adverse perinatal outcomes (e.g., preterm birth, low birth weight).  
  - The **non-significant odds ratio (OR 0.59; 95% CI 0.19–1.85)** confirms no statistically meaningful difference in CPM rates between groups.  
  - The study’s **conclusion** explicitly states that CPM is unlikely to explain adverse outcomes in IVF/ICSI, as the expected increase in CPM (if it were a cause) is not observed.  

- **Critical Reasoning**:  
  - If CPM were a major contributor to adverse outcomes in IVF, one would expect higher CPM rates in IVF pregnancies compared to spontaneous conceptions. The **inverse trend** (lower CPM in IVF) further weakens the hypothesis.  
  - The **small IVF sample size (235)** limits the study’s power to detect rare events like CPM. However, the study’s conclusion remains valid because the direction of the CPM rate difference (lower in IVF) contradicts the hypothesis that CPM drives adverse outcomes.  

- **Additional Consideration**:  
  - The abstract notes that fetal chromosomal anomalies were also not significantly increased in IVF (4.3% vs. 2.4%; OR 1.81; 95% CI 0.95–3.42). This further suggests that chromosomal abnormalities (including those associated with CPM) are not the primary drivers of adverse outcomes in IVF.  

**4. Self-Questioning**  
- **Has the rationale for my original choice been refuted?**  
  No. The arguments from GPT and DeepSeek reinforce my original conclusion. The data consistently show no increased CPM in IVF, and the study’s design supports its conclusion.  
- **Is the new choice better than my original choice?**  
  No change is needed. My original "no" remains valid.  
- **Why maintain the choice?**  
  The evidence directly refutes the hypothesis that CPM explains adverse outcomes in IVF. The lower CPM rate in IVF pregnancies, combined with non-significant statistical associations, provides strong support for rejecting this causal link.  

**5. Final Decision**  
**My final choice is: "no"**
Qwen selected: no

----------------------- DeepSeek's response -----------------------
DeepSeek is generating the response...


**1. Position Statement**  
**I agree with the shared viewpoint of GPT and Qwen** because their analyses align with the study’s evidence and reinforce my original conclusion.  

**2. Evaluation of Other Models**  
- **GPT’s analysis** correctly emphasizes the lack of statistical significance in CPM rates and fetal anomalies but understates the impact of the small IVF sample size (n=235) and wide confidence intervals, which reduce the study’s power to detect subtle differences.  
- **Qwen’s analysis** effectively highlights the inverse trend (lower CPM in IVF) as contradictory to the hypothesis but could strengthen its argument by explicitly linking the study’s limitations (e.g., retrospective design) to the robustness of the conclusion.  

**3. Medical Analysis and Argumentation**  
- **Critical Evidence**:  
  - The **lower CPM incidence in IVF/ICSI (1.3% vs. 2.2%)**, even if non-significant, directly contradicts the hypothesis that CPM drives adverse outcomes. A causal mechanism would require higher CPM rates in IVF.  
  - The study’s **multi-center design** and large control group (n=1,813) enhance generalizability, but the small IVF cohort limits statistical power. Despite this, the directionality of the data (lower CPM in IVF) remains a valid counterargument.  
  - **Fetal chromosomal anomalies**, though numerically higher in IVF (4.3% vs. 2.4%), lack statistical significance (OR 1.81; 95% CI 0.95–3.42), further dissociating chromosomal abnormalities (including CPM) from adverse outcomes.  

- **Unaddressed Nuance**:  
  - The retrospective design introduces potential confounding (e.g., IVF protocols, maternal age), but the abstract does not mention adjustments for these variables. This limitation weakens causal inference but does not invalidate the primary finding of no CPM increase.  
  - While the study’s conclusion is definitive, the wide CPM confidence interval (0.19–1.85) leaves room for uncertainty. However, the upper bound (1.85) still does not suggest a clinically meaningful increase in CPM risk.  

**4. Self-Questioning**  
- **Has the rationale for my original choice been completely refuted?**  
  No. The shared arguments of GPT and Qwen corroborate my original analysis. The study’s data and conclusion remain consistent with rejecting CPM as a causal factor.  
- **Is the new choice better than my original choice?**  
  No change is needed. The evidence and logical reasoning (e.g., inverse CPM trend) strongly support "no."  
- **Why persist with the choice?**  
  The study’s limitations (e.g., sample size) do not outweigh the lack of association between CPM and adverse outcomes. The absence of a plausible biological mechanism (given lower CPM rates in IVF) further justifies maintaining "no."  

**5. Final Decision**  
**My final choice is: "no"**
DeepSeek selected: no

Consensus reached: All models selected no